Multimodal Monitoring Study in Neuro Critical Care

Launched by HOSPICES CIVILS DE LYON · Mar 21, 2025

Keywords

ClinConnect Summary

The Multimodal Monitoring Study in Neuro Critical Care is a clinical trial aimed at understanding how the brain responds after serious injuries, like bleeding in the brain or trauma. During the first week after such an injury, doctors often cannot fully assess a patient's brain function because they may be sedated or unable to communicate. This study will use various monitoring tools to measure brain activity, oxygen levels, and other important signs to help prevent further brain damage. The goal is to learn more about how the brain behaves during this critical time and to find potential indicators that can help doctors better manage care.

To participate in this study, individuals must be hospitalized in the neurological critical care unit at Wertheimer Hospital in Bron and be monitored with a specific system called the CNS MOBERG®. The trial is open to adults aged between 18 and 89, regardless of gender. Participants can expect regular monitoring and assessments related to their brain function during their hospital stay. It's important to note that anyone who does not wish to participate or is under legal protection cannot join the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Patients hospitalized in neurologic critical care in Wertheimer Hospital, Bron
• • Monitored with the CNS MOBERG® monitoring system
• Exclusion Criteria:
• • - Refusal to participate
• • Patients under legal protection